Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 945 followers.

Pooled Analysis of 8 Phase II/III Studies: The most commonly reported AEs (>10%) in the overall cariprazine-treatment group were akathisia (14.6%), insomnia (14.0%), and headache (12.1%). Other AEs: EPS (7.0%), sedation (3.7%), and somnolence (3.1%) htt

09 Apr 2021

Reply Repost Favourite

[Full text] Cariprazine for the treatment of adults with schizophrenia | NDT - Dove Medical Press https://t.co/eV3H4eOJoT

07 Apr 2021